Pursuant to the provisions of Regulation 30 SEBI (LODR) Regulations 2015, the company has received the In - Principle Approval under Regulation 28(1) SEBI (LODR) for the issue and proposed ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Hamps Bio Ltd has received a revised in-principle approval from BSE on August 12, 2025, for a proposed bonus issue of up to 43,56,000 equity shares of Rs. 10 each. The bonus ratio is 1:1, meaning one new equity share for every one existing share held. This is still subject to shareholder approval and other regulatory compliances. The total bonus shares being allotted represent an equal expansion of the existing share base. The filing is made under Regulation 30 of SEBI (LODR) Regulations, 2015.
If approved by shareholders, eligible investors will receive additional shares at no extra cost, effectively doubling their holding quantity. In the short term, the stock may see price adjustment (ex-bonus) reflecting the dilution, while long-term impact depends on the company's fundamentals and use of the expanded capital base.